Merida Biosciences

Biotech · Cambridge, MA · Founded 2022 · Privately Held (backing)

Developer of targeted immunotherapies designed for the treatment of autoimmune and allergic diseases. Merida Biosciences is based in Cambridge, MA and was founded in 2022. It was valued at $228 million at its early-stage round in Apr 2025, the last priced event on record. It has raised $154 million across 1 recorded round; the latest was a $121 million Series A in Apr 2025.

PMV mark · valuation
$228.0M
Oct 2026
Priced at
its early-stage round
Apr 2025
Total raised
$154.0M
Last round
Series A
Apr 2025
What is Merida Biosciences worth?
$228.0MPrivateMarketView mark · Oct 2026

Valued at $228.0M at its early-stage round, Apr 2025. Nothing has traded since.

Free account
More of Merida Biosciences with a free account
  • ·Everyone on the team, board and advisors included
  • ·Watch Merida Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Merida Biosciences funding history

1 rounds
DateRoundRaisedPost-money
Apr 2025Series A$121.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Merida Biosciences valuation

Merida Biosciences was valued at $228 million at its early-stage round in Apr 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Merida Biosciences raised?

Merida Biosciences has raised $154 million in total; 1 of its rounds is on record. The largest on record was a $121 million Series A in Apr 2025.

Comparable companies

Comparable biotech names by valuation on PrivateMarketView: Chai Discovery ($1.3 billion), Nuwacell ($203 million) and InduPro ($125 million).

How Merida Biosciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Merida Biosciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Merida Biosciences

What is Merida Biosciences worth?
Merida Biosciences is valued at $228.0M as of Oct 2026. Valued at $228.0M at its early-stage round, Apr 2025. Nothing has traded since.
How much has Merida Biosciences raised?
Merida Biosciences has raised $154.0M in total funding across 1 recorded rounds.
When did Merida Biosciences last raise?
Merida Biosciences last raised in Apr 2025 (Series A), raising $121.0M.